OLMA Earnings

Quarterly EPS
$-0.60
Q3 2024
$-0.51
Q4 2024
$-0.36
Q1 2025
$-0.51
Q2 2025
$-0.49
Q3 2025
$-0.50
Q4 2025
$-0.52
Q1 2026
$-0.61
Q2 2026
Latest RevenueN/A
Latest Net Income-63200000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.610-63200000—-19.6%
Q1 2026-$0.520-53089000—-44.4%
Q4 2025-$0.500-46061000—+2.0%
Q3 2025-$0.490-42217000—+18.3%
Q2 2025-$0.510-43784000—+5.6%
Q1 2025-$0.360-30389000—+35.7%
Q4 2024-$0.510-33567000—-4.1%
Q3 2024-$0.600-34555000—-25.0%
Q2 2024-$0.540-30382000——
Q1 2024-$0.560-30970000——
Q4 2023-$0.490-26772000——
Q3 2023-$0.480-21502000——
Olema Pharmaceuticals (OLMA) — Earnings